# NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE
> **ANDA203978** · Abbreviated New Drug Application (Generic) · Sponsor: INFORLIFE · Approved 2024-04-17
## Drug
- **FDA Application Number:** ANDA203978
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE
- **Generic name:** NICARDIPINE HYDROCHLORIDE
- **Active ingredients:** NICARDIPINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** INFORLIFE
- **Manufacturer:** WG Critical Care, LLC
- **First approval:** 2024-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203978)
---
*AI Analytics · CC0 1.0*